Tuesday, December 4, 2012
AliveCor's heart monitor approved by FDA
AliveCor CEO Judy Wade, explained that the device can be used to monitor patients symptoms that appear when they're not at the doctor's office. It can record the irregular heart activity, and save it for the patient's next appointment. Patients diagnosed with heart disease, such as Atrial Fibrillation, can use the device to record and monitor the progress of their medication while at home. The heart monitor can also be used for preventive measures, such as catching arrhythmia's that could potentially be life threatening.
So how does it work? The device incorporates electrodes into a case that snaps onto the back of an iPhone 4 or 4S. The Heart Monitor is used by launching the corresponding AliveECG app on the iPhone, holding the device in a relaxed state, and pressing fingers from each hand to each of the two appropriate electrodes on the device. The device can also be used to obtain an ECG by placing it on the chest.
Although they will require FDA approval, the company also plans to launch a droid version of the monitor, as well as a 'Pad' version down the road.
With the Pharma slowly transitioning to the digital world, what types of programs and applications do you think we can expect for 2013?
As consumers integrate digital channels deeper into their daily lives, opportunities are rapidly opening up for Pharma brands to support the health needs of consumers across all areas. At the ePharma Summit, Christine Sakdalan, Vice President Diabetes Marketing, Patient Centric Strategy and Solutions, Novo Nordisk discusses the importance of understanding additional benefits to mobile, in our Making the Move to Digital: Lessons Learned from a Digital Outsider and Insider. To view the 2013 program, download the agenda and join us this March 4-6 in New York, NY at the 12th annual ePharma Summit.
As a reader of the ePharma Summit blog, you get a 10% discount off the current rate when using code XP1806BLOG to register.